PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 2159-2167

  Deng, Xinzhou ^a   Hu, Yi ^b   Ding, Qianshan ^a   Han, Rongfei ^a   Guo, Qian ^a   Qin, Jian ^a   Li, Jie ^c   Xiao, Ruijing ^a   Tian, Sufang ^d   Hu, Weidong ^d   Zhang, Qiuping ^a   Xiong, Jie ^a  

^a WUHAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c TaiHe Hospital of HuBei Province   (China)

^d ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Lung cancer; Metastasis; PEG10; Proliferation; SiRNA

Indexed keywords

BETA CATENIN; GELATINASE A; GELATINASE B; PROTEIN P53; UVOMORULIN; PEG10 PROTEIN, HUMAN; PROTEIN; SMALL INTERFERING RNA;

ADULT; AGE DISTRIBUTION; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL LINE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC CORRELATION; GENETIC DATABASE; GENETIC MARKER; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NON SMALL CELL LUNG CANCER; PEG10 GENE; PROTEIN INTERACTION; TUMOR INVASION; UPREGULATION; AGED; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; DATABASES, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROTEINS; RNA, SMALL INTERFERING;

EID: 84907284103     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3469     Document Type: Article

References (38)

1. Ono R, Kobayashi S, Wagatsuma H, et al: A retrotransposonderived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics 73: 232-237, 2001.
2. Li CM, Margolin AA, Salas M, et al: PEG10 is a c-MYC target gene in cancer cells. Cancer Res 66: 665-672, 2006.
3. Tsou AP, Chuang YC, Su JY, et al: Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 10: 625-635, 2003.
4. Tsuji K, Yasui K, Gen Y, et al: PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma. Cancer Genet Cytogenet 198: 118-125, 2010.
5. Lux H, Flammann H, Hafner M and Lux A: Genetic and molecular analyses of PEG10 reveal new aspects of genomic organization, transcription and translation. PLoS One 5: e8686, 2010.
6. Okabe H, Satoh S, Furukawa Y, et al: Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 63: 3043-3048, 2003.
7. Kainz B, Shehata M, Bilban M, et al: Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia. Int J Cancer 121: 1984-1993, 2007.
8. Liu DC, Yang ZL and Jiang S: Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Pathol Oncol Res 17: 859-866, 2011.
9. Ono R, Nakamura K, Inoue K, et al: Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality. Nat Genet 38: 101-106, 2006.
10. Smallwood A, Papageorghiou A, Nicolaides K, et al: Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta. Biol Reprod 69: 286-293, 2003.
11. +B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. Cell Mol Immunol 1: 280-294, 2004.
12. +B cells. J Immunol 177: 6713-6722, 2006.
13. Xiong J, Qin J, Zheng Y, et al: PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and-9. Clin Invest Med 35: E117-E125, 2012.
14. UyBico SJ, Wu CC, Suh RD, et al: Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. Radiographics 30: 1163-1181, 2010.
15. Murchison JT: TNM staging update for lung cancer: why is this important? World J Radiol 4: 126-127, 2012.
16. Han R, Xiong J, Xiao R, et al: Activation of β-catenin signaling is critical for doxorubicin-induced epithelial-mesenchymal transition in BGC-823 gastric cancer cell line. Tumor Biol 34: 277-284, 2013.
17. Huang Q, Gumireddy K, Schrier M, et al: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210, 2008.
18. Teng Y, Wang X, Wang Y and Ma D: Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392: 373-379, 2010.
19. Yang L, Chen Y, Cui T, et al: Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Carcinogenesis 33: 1863-1870, 2012.
20. Su K, Huang L, Li W, et al: TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway. J Surg Res 185: 255-263, 2013.
21. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
22. Acloque H, Adams MS, Fishwick K, et al: Epithelial.mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119: 1438-1449, 2009.
23. Nieto MA: Epithelial-mesenchymal transitions in development and disease: old views and new perspectives. Int J Dev Biol 53: 1541-1547, 2009.
24. Shintani Y, Okimura A, Sato K, et al: Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg 92: 1794-1804, 2011.
25. Lee KR, Lee JS, Kim YR, et al: Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP.2 and MMP.9 via downregulation of NF-κB signaling pathway. Oncol Rep 31: 2447-2453, 2014.
26. Liu N, Li Y, Su S, et al: Inhibition of cell migration by ouabain in the A549 human lung cancer cell line. Oncol Lett 6: 475-479, 2013.
27. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
28. Malvezzi M, Bertuccio P, Levi F, et al: European cancer mortality predictions for the year 2013. Ann Oncol 24: 792-800, 2013.
29. Goldstraw P, Crowley J, Chansky K, et al: The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of Malignant Tumours. J Thorac Oncol 2: 706-714, 2007.
30. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
31. Heuberger J and Birchmeier W: Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2: a002915, 2010.
32. Johnson M, Sharma M, Jamieson C, et al: Regulation of β-catenin trafficking to the membrane in living cells. Cell Signal 21: 339-348, 2009.
33. Valenta T, Hausmann G and Basler K: The many faces and functions of β-catenin. EMBO J 31: 2714-2736, 2012.
34. Baum B, Settleman J and Quinlan MP: Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308, 2008.
35. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
36. Yang MH, Chen CL, Chau GY, et al: Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474, 2009.
37. McDonnell S, Morgan M and Lynch C: Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans 27: 734-740, 1999.
38. Shuman Moss LA, Jensen-Taubman S and Stetler-Stevenson WG: Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol 181: 1895-1899, 2012.